Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23710)

Formulation Name
Diazoxide 1.5g/30ml suspension
Company
Teva Pharmaceuticals Usa
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Diazoxide DML1538 Congenital hyperinsulinism 5A4Y Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Carboxymethylcellulose sodium E00621 Not Available Adsorbent; Binding agent; Disintegrant; Emulsifying agent; Suspending agent; Viscosity-controlling agent
Ethanol E00023 702 Antimicrobial preservative; Penetration agent; Solvent
Hydrochloric acid E00015 313 Acidulant
Magnesium aluminum silicate E00462 3084116 Adsorbent; Binding agent; Disintegrant; Suspending agent; Viscosity-controlling agent
methylparaben E00149 7456 Antimicrobial preservative
Poloxamer 188 E00645 Not Available Emulsifying agent; Solubilizing agent; Surfactant
Propylene glycol E00040 1030 Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Propylparaben sodium E00567 23679044 Antimicrobial preservative
Sodium benzoate E00432 517055 Antimicrobial preservative; lubricant
Sodium hydroxide E00234 14798 Alkalizing agent
Sorbitan tristearate E00516 17800859 Dispersing agent; Emulsifying agent; Solubilizing agent; Surfactant; Suspending agent; Vaccine adjuvant